Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Assets (2016 - 2025)

Historic Return on Assets for Standard Biotools (LAB) over the last 15 years, with Q3 2025 value amounting to 0.22%.

  • Standard Biotools' Return on Assets fell 1100.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.3% for FY2024, which is 900.0% down from last year.
  • As of Q3 2025, Standard Biotools' Return on Assets stood at 0.22%, which was down 1100.0% from 0.21% recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Return on Assets registered a high of 0.11% during Q3 2024, and its lowest value of 0.47% during Q4 2022.
  • For the 5-year period, Standard Biotools' Return on Assets averaged around 0.26%, with its median value being 0.22% (2023).
  • As far as peak fluctuations go, Standard Biotools' Return on Assets crashed by -2600bps in 2022, and later skyrocketed by 2500bps in 2023.
  • Standard Biotools' Return on Assets (Quarter) stood at 0.21% in 2021, then crashed by -122bps to 0.47% in 2022, then soared by 52bps to 0.23% in 2023, then rose by 9bps to 0.2% in 2024, then decreased by -7bps to 0.22% in 2025.
  • Its Return on Assets stands at 0.22% for Q3 2025, versus 0.21% for Q2 2025 and 0.21% for Q1 2025.